Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPARE
NCT02788227Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- Oct 2016
- Primary completion
- Jun 2025
- Modality
- Viral Vector Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of Ebola Zaire vaccine (live, attenuated) in Ebola virus disease (EVD), sponsored by National Institutes of Health. Started Oct 2016; status: completed.
02
Drugs
Ebola Zaire vaccine (live, attenuated)
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT02788227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02788227.